Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
745.90Prev. Close
747.00Volume
1,42,207Total traded value
10.60 CrUpper Circuit
896.40Lower Circuit
597.60Fundamentals
| Market Cap | ₹6,016Cr |
| ROE | 18.86% |
| P/E Ratio(TTM) | 33.78 |
| EPS(TTM) | 22.13 |
| P/B Ratio | 6.04 |
| Dividend Yield | 0.13% |
| Industry P/E | 41.14 |
| Book Value | 123.85 |
| Debt to Equity | 0.01 |
| Face Value | 2 |
Understand Fundamentals
Financials
About Supriya Lifescience
Supriya Lifescience Limited is a renowned manufacturer of active pharmaceutical ingredients (APIs), having converted from a partnership to a public limited company in 2008. The company is committed to enhancing value for all of its stakeholders in a sustainable way, strengthening its business for the future. Highlighting its robust growth, the company's net profit increased by 33% to ₹119 crore in the 2023-24 financial year.;
| Parent Organisation | Supriya Lifescience |
| Managing Director | Mr. Satish Wagh |
| NSE Symbol | SUPRIYA |
Shareholding Pattern
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 103.18 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 39.33 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.60 | ||
| Wockhardt | NA (0.00%) | -195.86 |